Detalhe da pesquisa
1.
Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype.
Genes Dev
; 32(5-6): 448-461, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567766
2.
Focus on cutaneous and uveal melanoma specificities.
Genes Dev
; 31(8): 724-743, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28512236
3.
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice.
Int J Mol Sci
; 24(13)2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37446253
4.
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
Mol Cancer
; 20(1): 12, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33413419
5.
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
Mol Cancer
; 19(1): 170, 2020 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33276788
6.
Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).
Genes Dev
; 25(12): 1245-61, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21646373
7.
Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Nature
; 531(7592): 126, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26633630
8.
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Nature
; 480(7375): 94-8, 2011 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22012259
9.
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
Mol Cancer
; 20(1): 21, 2021 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504341
10.
Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells.
J Biol Chem
; 287(35): 29887-98, 2012 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22767597
11.
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade.
Oncoimmunology
; 12(1): 2158610, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545256
12.
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank.
Cancers (Basel)
; 15(8)2023 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190299
13.
Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability.
Cell Rep
; 42(11): 113363, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924516
14.
Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion.
Cell Stem Cell
; 30(6): 800-817.e9, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37267915
15.
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
EMBO Mol Med
; 15(12): e17719, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966164
16.
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
Cancers (Basel)
; 14(19)2022 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230787
17.
MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells.
Commun Biol
; 5(1): 101, 2022 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091687
18.
Recent advances in understanding the role of HES6 in cancers.
Theranostics
; 12(9): 4374-4385, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35673577
19.
Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy?
Exp Dermatol
; 20(12): 1030-2, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22092579
20.
Cutaneous and uveal melanoma: two different cancers in therapeutic needs.
C R Biol
; 344(3): 219-231, 2021 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35786627